Has there been any improvement in the staging of gastric cancer?. Findings from the German gastric cancer TNM study group
This multicenter observational study examined the survival of 1420 patients with histologically proven carcinoma of the stomach. From April 1982 through October 1984, 1360 (95%) patients underwent surgery, 988 (72%) had resections, and 372 (28%) minor surgical procedures. The percentage of patients...
Gespeichert in:
Veröffentlicht in: | Cancer 1989-12, Vol.64 (12), p.2465-2481 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2481 |
---|---|
container_issue | 12 |
container_start_page | 2465 |
container_title | Cancer |
container_volume | 64 |
creator | Rohde, Henning Gebbensleben, Brigitte Bauer, Peter Stützer, Hartmut Zieschang, Jürgen |
description | This multicenter observational study examined the survival of 1420 patients with histologically proven carcinoma of the stomach. From April 1982 through October 1984, 1360 (95%) patients underwent surgery, 988 (72%) had resections, and 372 (28%) minor surgical procedures. The percentage of patients who have been followed until death or 3 to 5 years was 99.4%. Patients were staged preoperatively and intraoperatively and by pathologists using the old (1978) and new (1987) TNM stage groupings and 5‐year survival was analyzed. Subgroups of patients who changed their stage group according to the new stage definitions were analyzed separately. Only age was an important prognostic factor for survival in Stage IA (P < 0.05) and Stage IB (P < 0.01). Residual tumor after surgery was most important for survival in Stage I1 (P < 0.01) and Stage IIIA (P < 0.001). This indicates that improvements of stage definitions for individual prognosis can only be achieved by adding data concerning the presence or absence of residual tumor (R classification). Cancer 64:2465–2481, 1989. |
doi_str_mv | 10.1002/1097-0142(19891215)64:12<2465::AID-CNCR2820641212>3.0.CO;2-Y |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79333617</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79333617</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5012-90d7b626730e6265dc64fa778104450b95866e9de3cf6114abc89db5d59e9fdb3</originalsourceid><addsrcrecordid>eNqVkV2L1DAYhYMo6zj6E4RciLgXHfPdZhSXpet-wLoDsoILQkiTtFb6MSat0n9v6owD7oXg1Us4Tw7vew4AZxitMELkNUYyTRBm5BWWmcQE82PB1pi8JUzw9fr06izJb_KPJCNIsCiTd3SFVvnmDUnuHoDF4ftDsEAIZQln9PNj8CSEb_GZEk6PwBERGaMZX4DpUgc4fHXewcK5DupugnW79f0P17pugHU3qzAMuqq7CvYlrHQYfG2g0Z1x_mQFz-vORi3A0vftb_rC-VZ390h4e_Mh-ox2gpXvx-1T8KjUTXDP9nMJPp2_v80vk-vNxVV-ep0YjjBJJLJpIYhIKXJxcGsEK3WaZhgxxlEheSaEk9ZRUwqMmS5MJm3BLZdOlragS_By5xuP-j66MKi2DsY1je5cPwaVSkqpwGkEv-xA4_sQvCvV1tet9pPCSM3NqDlaNUer_jSjBFOYqLkZpWIz6u9mFFVI5RtF1F20f77fYyxaZw_m-yqi_mKv62B0U_qYWh0OWAxAsEguQbXDftaNm_5zxX9ueE-hvwBdPbiu</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79333617</pqid></control><display><type>article</type><title>Has there been any improvement in the staging of gastric cancer?. Findings from the German gastric cancer TNM study group</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Rohde, Henning ; Gebbensleben, Brigitte ; Bauer, Peter ; Stützer, Hartmut ; Zieschang, Jürgen</creator><creatorcontrib>Rohde, Henning ; Gebbensleben, Brigitte ; Bauer, Peter ; Stützer, Hartmut ; Zieschang, Jürgen</creatorcontrib><description>This multicenter observational study examined the survival of 1420 patients with histologically proven carcinoma of the stomach. From April 1982 through October 1984, 1360 (95%) patients underwent surgery, 988 (72%) had resections, and 372 (28%) minor surgical procedures. The percentage of patients who have been followed until death or 3 to 5 years was 99.4%. Patients were staged preoperatively and intraoperatively and by pathologists using the old (1978) and new (1987) TNM stage groupings and 5‐year survival was analyzed. Subgroups of patients who changed their stage group according to the new stage definitions were analyzed separately. Only age was an important prognostic factor for survival in Stage IA (P < 0.05) and Stage IB (P < 0.01). Residual tumor after surgery was most important for survival in Stage I1 (P < 0.01) and Stage IIIA (P < 0.001). This indicates that improvements of stage definitions for individual prognosis can only be achieved by adding data concerning the presence or absence of residual tumor (R classification). Cancer 64:2465–2481, 1989.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/1097-0142(19891215)64:12<2465::AID-CNCR2820641212>3.0.CO;2-Y</identifier><identifier>PMID: 2684385</identifier><identifier>CODEN: CANCAR</identifier><language>eng</language><publisher>New York: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Biological and medical sciences ; Female ; Gastrectomy ; Gastroenterology. Liver. Pancreas. Abdomen ; Germany, West ; Humans ; Male ; Medical sciences ; Middle Aged ; Multicenter Studies as Topic ; Neoplasm Metastasis ; Neoplasm Staging - standards ; Stomach Neoplasms - mortality ; Stomach Neoplasms - pathology ; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus ; Tumors</subject><ispartof>Cancer, 1989-12, Vol.64 (12), p.2465-2481</ispartof><rights>Copyright © 1989 American Cancer Society</rights><rights>1990 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c5012-90d7b626730e6265dc64fa778104450b95866e9de3cf6114abc89db5d59e9fdb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=6736484$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2684385$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rohde, Henning</creatorcontrib><creatorcontrib>Gebbensleben, Brigitte</creatorcontrib><creatorcontrib>Bauer, Peter</creatorcontrib><creatorcontrib>Stützer, Hartmut</creatorcontrib><creatorcontrib>Zieschang, Jürgen</creatorcontrib><title>Has there been any improvement in the staging of gastric cancer?. Findings from the German gastric cancer TNM study group</title><title>Cancer</title><addtitle>Cancer</addtitle><description>This multicenter observational study examined the survival of 1420 patients with histologically proven carcinoma of the stomach. From April 1982 through October 1984, 1360 (95%) patients underwent surgery, 988 (72%) had resections, and 372 (28%) minor surgical procedures. The percentage of patients who have been followed until death or 3 to 5 years was 99.4%. Patients were staged preoperatively and intraoperatively and by pathologists using the old (1978) and new (1987) TNM stage groupings and 5‐year survival was analyzed. Subgroups of patients who changed their stage group according to the new stage definitions were analyzed separately. Only age was an important prognostic factor for survival in Stage IA (P < 0.05) and Stage IB (P < 0.01). Residual tumor after surgery was most important for survival in Stage I1 (P < 0.01) and Stage IIIA (P < 0.001). This indicates that improvements of stage definitions for individual prognosis can only be achieved by adding data concerning the presence or absence of residual tumor (R classification). Cancer 64:2465–2481, 1989.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Female</subject><subject>Gastrectomy</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Germany, West</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Multicenter Studies as Topic</subject><subject>Neoplasm Metastasis</subject><subject>Neoplasm Staging - standards</subject><subject>Stomach Neoplasms - mortality</subject><subject>Stomach Neoplasms - pathology</subject><subject>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</subject><subject>Tumors</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1989</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkV2L1DAYhYMo6zj6E4RciLgXHfPdZhSXpet-wLoDsoILQkiTtFb6MSat0n9v6owD7oXg1Us4Tw7vew4AZxitMELkNUYyTRBm5BWWmcQE82PB1pi8JUzw9fr06izJb_KPJCNIsCiTd3SFVvnmDUnuHoDF4ftDsEAIZQln9PNj8CSEb_GZEk6PwBERGaMZX4DpUgc4fHXewcK5DupugnW79f0P17pugHU3qzAMuqq7CvYlrHQYfG2g0Z1x_mQFz-vORi3A0vftb_rC-VZ390h4e_Mh-ox2gpXvx-1T8KjUTXDP9nMJPp2_v80vk-vNxVV-ep0YjjBJJLJpIYhIKXJxcGsEK3WaZhgxxlEheSaEk9ZRUwqMmS5MJm3BLZdOlragS_By5xuP-j66MKi2DsY1je5cPwaVSkqpwGkEv-xA4_sQvCvV1tet9pPCSM3NqDlaNUer_jSjBFOYqLkZpWIz6u9mFFVI5RtF1F20f77fYyxaZw_m-yqi_mKv62B0U_qYWh0OWAxAsEguQbXDftaNm_5zxX9ueE-hvwBdPbiu</recordid><startdate>19891215</startdate><enddate>19891215</enddate><creator>Rohde, Henning</creator><creator>Gebbensleben, Brigitte</creator><creator>Bauer, Peter</creator><creator>Stützer, Hartmut</creator><creator>Zieschang, Jürgen</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley-Liss</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19891215</creationdate><title>Has there been any improvement in the staging of gastric cancer?. Findings from the German gastric cancer TNM study group</title><author>Rohde, Henning ; Gebbensleben, Brigitte ; Bauer, Peter ; Stützer, Hartmut ; Zieschang, Jürgen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5012-90d7b626730e6265dc64fa778104450b95866e9de3cf6114abc89db5d59e9fdb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1989</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Female</topic><topic>Gastrectomy</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Germany, West</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Multicenter Studies as Topic</topic><topic>Neoplasm Metastasis</topic><topic>Neoplasm Staging - standards</topic><topic>Stomach Neoplasms - mortality</topic><topic>Stomach Neoplasms - pathology</topic><topic>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rohde, Henning</creatorcontrib><creatorcontrib>Gebbensleben, Brigitte</creatorcontrib><creatorcontrib>Bauer, Peter</creatorcontrib><creatorcontrib>Stützer, Hartmut</creatorcontrib><creatorcontrib>Zieschang, Jürgen</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rohde, Henning</au><au>Gebbensleben, Brigitte</au><au>Bauer, Peter</au><au>Stützer, Hartmut</au><au>Zieschang, Jürgen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Has there been any improvement in the staging of gastric cancer?. Findings from the German gastric cancer TNM study group</atitle><jtitle>Cancer</jtitle><addtitle>Cancer</addtitle><date>1989-12-15</date><risdate>1989</risdate><volume>64</volume><issue>12</issue><spage>2465</spage><epage>2481</epage><pages>2465-2481</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><coden>CANCAR</coden><abstract>This multicenter observational study examined the survival of 1420 patients with histologically proven carcinoma of the stomach. From April 1982 through October 1984, 1360 (95%) patients underwent surgery, 988 (72%) had resections, and 372 (28%) minor surgical procedures. The percentage of patients who have been followed until death or 3 to 5 years was 99.4%. Patients were staged preoperatively and intraoperatively and by pathologists using the old (1978) and new (1987) TNM stage groupings and 5‐year survival was analyzed. Subgroups of patients who changed their stage group according to the new stage definitions were analyzed separately. Only age was an important prognostic factor for survival in Stage IA (P < 0.05) and Stage IB (P < 0.01). Residual tumor after surgery was most important for survival in Stage I1 (P < 0.01) and Stage IIIA (P < 0.001). This indicates that improvements of stage definitions for individual prognosis can only be achieved by adding data concerning the presence or absence of residual tumor (R classification). Cancer 64:2465–2481, 1989.</abstract><cop>New York</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>2684385</pmid><doi>10.1002/1097-0142(19891215)64:12<2465::AID-CNCR2820641212>3.0.CO;2-Y</doi><tpages>17</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0008-543X |
ispartof | Cancer, 1989-12, Vol.64 (12), p.2465-2481 |
issn | 0008-543X 1097-0142 |
language | eng |
recordid | cdi_proquest_miscellaneous_79333617 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | Adult Aged Aged, 80 and over Biological and medical sciences Female Gastrectomy Gastroenterology. Liver. Pancreas. Abdomen Germany, West Humans Male Medical sciences Middle Aged Multicenter Studies as Topic Neoplasm Metastasis Neoplasm Staging - standards Stomach Neoplasms - mortality Stomach Neoplasms - pathology Stomach. Duodenum. Small intestine. Colon. Rectum. Anus Tumors |
title | Has there been any improvement in the staging of gastric cancer?. Findings from the German gastric cancer TNM study group |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T05%3A16%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Has%20there%20been%20any%20improvement%20in%20the%20staging%20of%20gastric%20cancer?.%20Findings%20from%20the%20German%20gastric%20cancer%20TNM%20study%20group&rft.jtitle=Cancer&rft.au=Rohde,%20Henning&rft.date=1989-12-15&rft.volume=64&rft.issue=12&rft.spage=2465&rft.epage=2481&rft.pages=2465-2481&rft.issn=0008-543X&rft.eissn=1097-0142&rft.coden=CANCAR&rft_id=info:doi/10.1002/1097-0142(19891215)64:12%3C2465::AID-CNCR2820641212%3E3.0.CO;2-Y&rft_dat=%3Cproquest_cross%3E79333617%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79333617&rft_id=info:pmid/2684385&rfr_iscdi=true |